Benicar HCT Side Effects

Some of the common Benicar HCT side effects include dizziness, nausea, and upper respiratory tract infections. Side effects that are rarer include diarrhea, heartburn, and muscle pain. Consult your healthcare provider immediately if you develop any of the more severe side effects, such as difficulty breathing, seizures, and confusion. However, in most cases, side effects of Benicar HCT are minor and easily treated.

 

An Overview of Benicar HCT Side Effects

As with any medicine, there are possible side effects associated with Benicar HCT® (olmesartan medoxomil hydrochlorothiazide). However, not everyone who takes Benicar HCT will experience side effects. In fact, most people tolerate the drug quite well. If Benicar HCT side effects do occur, in many cases, they are minor, meaning they require no treatment or are easily treated by you or a healthcare provider. Serious side effects can occur, but are less common.
 
(This article covers many, but not all, of the possible side effects with Benicar HCT. Your healthcare provider can discuss a more complete list of Benicar HCT side effects with you.)
 

Common Side Effects of Benicar HCT

There have been extensive clinical trials that have evaluated thousands of people worldwide who were taking Benicar HCT.
 In these studies, side effects were always documented and compared to side effects that occurred in a similar group of people not taking the medicine. This way, it is possible to see what side effects occur, how often they appear, and how they compare to the group not taking the medicine.
 
Based on these studies, the most common Benicar HCT side effects include:
 
  • Dizziness -- occurring in up to 9 percent of people
  • Upper respiratory tract infections, such as the flu or common cold -- up to 7 percent
  • Increased uric acid levels in the blood -- up to 4 percent
  • Nausea -- up to 3 percent.
     
Other side effects occurring in more than 1 percent of people include but are not limited to:
 
(Benicar HCT Side Effects Continued: Page 2)
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;